Sharp increase in gabapentin dispensing highlights need for awareness of adverse effects

A cross-sectional study examined dispensing of anticonvulsant gabapentin from retail pharmacies in the United States from 2010 to 2024. The findings revealed a slow but increasing rate of gabapentin prescribing since 2026, with gabapentin becoming the 5th most prescribed medication in 2024 compared with the 10th most prescribed in 2017.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup